Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MRK

3 Pharmaceutical Stocks With Strong Pipelines

The pharmaceutical industry is flourishing due to increasing medical demands and rising healthcare spending worldwide. Hence, pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck & Co. (MRK), with strong pipelines, might be worth buying. Read more….

3 Dow Dividend Stocks Beating the Market This Year

3 Dow Dividend Stocks Beating the Market This Year

While all eyes are still on standout AI tech stocks, these three dividend-paying Dow stocks are beating the broader market this year.

Is Merck & Company Stock Outperforming the Dow

Is Merck & Company Stock Outperforming the Dow

Merck & Company has significantly outperformed the Dow Jones recently, and Wall Street analysts expect further gains for the stock.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Do Wall Street Analysts Like Merck & Company Stock?

As Merck outperforms the broader market this year, Wall Street analysts remain optimistic about the stock's prospects.

3 A-Rated Pharma Stocks to Buy for Long-Term Growth

With surging medical needs, advances in precision medicine, and the adoption of generative AI, the pharmaceutical industry is thriving. Thus, it could be ideal to invest in quality pharma stocks Taro Pharmaceutical (TARO), AstraZeneca (AZN), and Merck (MRK) for long-term growth. These stocks are rated A (Strong Buy) in our…

Stocks Plunge Before the Open as Meta’s Revenue Forecast Disappoints, U.S. GDP Data and Earnings in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.87% this morning as a disappointing revenue outlook for the current quarter from Meta weighed on sentiment, while market participants braced for a new round of U.S. economic data and quarterly reports…

Merck (MRK) vs. AbbVie (ABBV): Which Pharma Stock Will Drive Earnings Growth?

The pharmaceutical industry is expected to expand significantly due to the ever-rising global medical needs and technological advances. In this scenario, let’s analyze the better investment option between popular pharma stocks, Merck &Co (MRK) and AbbVie (ABBV).

inkl

Read news from The Economist, FT, and more,
with one subscription

4 Pharma Giants Sparking Investor Interest

4 Pharma Giants Sparking Investor Interest

The pharmaceutical industry is growing steadily, focusing more on technological innovation, precision medicine, and strategic mergers and acquisitions (M&A). So, let’s take a look at pharma giants Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) igniting investor interest. Keep reading….

Aurora Cannabis (ACB) vs. Merck (MRK): Which Pharma Stock Holds Greater Potential for Investors?

Aurora Cannabis (ACB) vs. Merck (MRK): Which Pharma Stock Holds Greater Potential for Investors?

The pharmaceutical industry is poised for robust growth owing to technological advancements and growing healthcare needs. Given this backdrop, let’s analyze Aurora Cannabis (ACB) and Merck & Co. (MRK) to determine which of the two stocks holds greater potential for investors. Read on….

3 Pharma Stocks Fueling Investor Enthusiasm

3 Pharma Stocks Fueling Investor Enthusiasm

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

4 Pharma Titans Making Waves in Wall Street

4 Pharma Titans Making Waves in Wall Street

The pharma industry is well-positioned to remain buoyed, owing to the rise in chronic diseases, a growing elderly population, and the integration of advanced technologies. Given this backdrop, quality pharma stocks Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ), Novartis AG (NVS), and Merck & Co. (MRK), making waves in…

3 Cheap Dividend Stocks to Scoop Up This March

3 Cheap Dividend Stocks to Scoop Up This March

After a second straight losing week for stocks, investors in search of relative safety in the market might want to consider value-priced dividend stocks - like the three income picks we've highlighted here.

3 Pharma Powerhouses for Long-Term Growth in 2024

3 Pharma Powerhouses for Long-Term Growth in 2024

Amid evolving technologies and strategic maneuvers, the pharma industry is set for paradigm-shifting growth, propelled by growing funding and drug discovery. Hence, fundamentally strong pharma stocks Collegium Pharmaceutical (COLL), AstraZeneca (AZN), and Merck & Co. (MRK) might be ideal buys this year for long-term growth. Read more….

Will These 3 Pharma Stocks Leave Investors Triumphant in 2024?

Will These 3 Pharma Stocks Leave Investors Triumphant in 2024?

The pharmaceutical industry is undergoing a transformative shift driven by the advent of personalized drugs, technological innovations, and growing usage. Against this backdrop, does the inclusion of pharma stocks CytomX Therapeutics (CTMX), Merck & Co (MRK), and Neurocrine Biosciences (NBIX) in your portfolio appear wise? Let’s find out….

Get all your
news in one place.

100's of premium titles.
One news app.

Merck (MRK): Quarterly Earnings - What Investors Should Know

Pharma giant Merck (MRK) has an impressive record of surpassing analysts’ expectations in its top and bottom lines. So, is the company on track to top estimates in the upcoming earnings release? Let’s discuss some of its financials to gauge its prospects.

3 Pharma Stock Buys for Last-Minute Year-End Profits

Growing healthcare spending and the use of cutting-edge technologies in the research and development of new drugs have put the pharmaceutical industry in a strong position for growth. With such constructive trends in mind, it's wise to buy fundamentally strong pharma stocks, Merck (MRK), Collegium (COLL) and Johnson & Johnson…

Are These 3 Pharma Stocks Smart Buys for Bullish Investors?

The pharmaceutical industry's outlook looks promising, given robust healthcare spending worldwide and the rapid adoption of advanced digital technologies. Amid this, let’s find out if pharma stocks AbbVie (ABBV), Collegium Pharmaceutical (COLL), and Merck (MRK) are ideal buys now. Read on to know more….

Analyzing Pharma Stock Giants: JNJ, MRK, and ABBV

The pharmaceutical industry is set for long-term growth due to growing demand for quality drugs and therapies, an aging population, and the rise in lifestyle-related diseases. Now, let's explore the investment potential of industry giants Merck & Co (MRK), Johnson & Johnson (JNJ), and AbbVie (ABBV). Keep reading.

Get all your
news in one place.

100's of premium titles.
One news app.

3 Pharma Stocks Providing Consistent Gains for Investors

The pharmaceutical industry is anticipated to be bolstered due to the increasing demand for chronic disease management and the rising requirements of an aging demographic. Given the industry’s solid prospects, investors could buy quality pharma stocks Eton Pharmaceuticals (ETON), Ipsen S.A. (IPSEY), and Merck & Co. (MRK) for consistent gains.…

Merck & Co. (MRK) Q3 Earnings Assessment: Is the Pharma Stock a Buy or Sell?

In the wake of Merck & Co.'s (MRK) better-than-expected fiscal third-quarter showing and the enigmatic potential hinted at by its clinical successes, is this pharmaceutical powerhouse a hidden gem for investors? Let's find out.

How To Buy MRK For A 5% Discount, Or Achieve An 13% Annual Return

Yesterday, with Merck trading at $103.94, the November put option with a strike price of $100 was trading around $1.78. Traders selling this put would receive $178 in option premium.

Prescribe to Profits With These 3 Pharma Stocks

The pharma industry looks well-positioned for solid growth in the long term amid the rising incidence of chronic illnesses and technological advancements. So, quality pharma stocks, Eli Lilly and Company (LLY), Merck & Co. (MRK), and Teva Pharmaceutical (TEVA) could be profitable investments. Read on.

3 Pharma Stocks to Buy Now for a Dose of Profit

The pharmaceutical sector is expanding due to advanced technologies such as AI and new drug discoveries. Hence, quality pharma stocks GoodRx Holdings (GDRX), Merck & Co. (MRK), and Sanofi (SNY) might be profitable investments right now. Read on.

Looking for a Value Investment? Check out These 3 Pharma Stocks

The pharmaceutical industry looks well-positioned for long-term growth. Therefore, fundamentally strong Merck & Co (MRK), Pfizer (PFE), and Lipocine (LPCN) could be ideal value investments now. Keep reading.

3 Pharma Stocks to Buy for Value Investors

The pharma industry is well-positioned to witness significant growth due to the continuous advancements in artificial intelligence and increasing demand for innovative drugs. Therefore, fundamentally strong pharma stocks Merck & Co. (MRK), Astellas Pharma (ALPMY), and Taro Pharmaceutical (TARO), which seem to be trading at a discount, might be solid…

1 … 3 4 5 6

People

Kritika SarmahHer

Steve Reitmeister

Neha PanjwaniFrom

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Intel Corporation

American Express

Johnson & Johnson (

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

357,452 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play